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Abstract: Cellular stress-induced temporal alterations—i.e., dynamics—are typically exemplified by
the dynamics of p53 that serve as a master to determine cell fate. p53 dynamics were initially identified
as the variations of p53 protein levels. However, a growing number of studies have shown that
p53 dynamics are also manifested in variations in the activity, spatial location, and posttranslational
modifications of p53 proteins, as well as the interplay among all p53 dynamical features. These are
essential in determining a specific outcome of cell fate. In this review, we discuss the importance of
the multifaceted features of p53 dynamics and their roles in the cell fate decision process, as well
as their potential applications in p53-based cancer therapy. The review provides new insights into
p53 signaling pathways and their potentials in the development of new strategies in p53-based
cancer therapy.
Keywords: p53 dynamics; cell fate decision; cell signaling network

1. Introduction
Cells are constantly bombarded by a variety of endogenous and environmental stress that results
in cellular damage. This usually leads to cell cycle arrest allowing the damage to be repaired by cellular
repair mechanisms. However, in an occasion of severe damage, cells have to directly activate a “suicide”
apoptotic death program to induce cell death, preventing initiation of oncogenic processes. Thus,
cells have two possible fates—to survive or die. Failure in making the right decision in determining
cell fate can ultimately lead to the development of diseases such as cancer. The cell fate decision
machinery is composed of multiple complex signaling pathways, in which p53, a key tumor suppressor,
plays a central role in coordinating the multiple cellular signaling pathways as well as determining
cell fate [1].
As a transcription factor, p53 is activated by various types of stimuli. This selectively regulates
the transcription of p53 target genes that subsequently mediate cellular responses to stress. In the past
two decades, hundreds of p53 target genes have been identified. These include the cyclin-dependent
kinase inhibitor P21 gene and pro-apoptotic genes such as BAX, BAK, PUMA, and P53AIP1 [2–4].
The proteins encoded by these genes are involved in inhibition of cell proliferation or activation of
apoptosis. In addition, several microRNAs, most notably the miR-34 family, that are involved in
cell cycle arrest, and large intergenic noncoding RNAs (lincRNAs) that are involved in transcription
repression, have also recently been identified as p53 target genes [5,6]. While the list of p53 target
genes keeps growing, the multiple components of the list build up a p53 signaling network providing
massive information about how p53 may promote cellular growth arrest or apoptosis. However,
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arrest, whereas prolonged p53 pulses induced by UV are involved in upregulation of pro-apoptotic
genes that can lead to apoptosis [17]. This is further supported by a study from the Lahav group [19]
showing that DNA damage induced by moderate doses of IR triggered transient pulses of p53.
This, in turn arrests the cell cycle, facilitating damage repair and cell survival. On the other hand,
sustainment of a high level of p53 protein with a small compound, Nutlin-3, that switches p53
dynamics from a pulsed mode to a sustained mode, leads to cell senescence [19]. The results suggest
that a specific dynamic pattern of p53 results in a specific cellular outcome. Thus, different patterns of
p53 dynamics can be “translated” into different downstream responses and cellular outcomes by the
downstream proteins in the p53 signaling pathway.
2.2. The Role of p53 Dynamics in Making Cell Fate Decisions
2.2.1. How Can Pulsatile p53 Dynamics Be Generated?
As a transcription factor, p53 can activate pro-cell cycle arrest and pro-apoptotic genes as well as
induce the expression of genes that regulate its own gene expression and the stability of its protein.
This results in the formation of a feedback loop leading to the pulsatile dynamics of p53 protein level.
The first identified feedback loop in the p53 network is the p53 mouse double minute 2 (Mdm2)
negative feedback loop. Discovered in 1992, Mdm2 was initially proposed as an oncoprotein because
it functions as a p53-specific E3 ubiquitin ligase that promotes ubiquitination and subsequent
proteasomal degradation of p53 [20]. Later it was found that the expression of Mdm2 is
transcriptionally regulated by p53 [21,22]. The relationship between p53 and Mdm2 has been further
elucidated by a computational model and is defined as a negative-feedback loop, where p53 increases
the expression of Mdm2, and this, in turn promotes the degradation of p53 protein [14]. The p53-Mdm2
feedback loop leads to oscillations with repeated increases and decreases in cellular p53 protein level
building up the basis of p53 dynamics. The existence of p53-Mdm2 negative feedback is further
supported by numerous studies [14,23,24] revealing that the dynamics of a signaling molecule is
constructed by a feedback loop formed between the components of the cellular signaling pathway.
Although the p53-Mdm2 negative feedback loop can serve as a basis of p53 dynamics, it is still
too simple for explaining the complex responses within the p53 signaling network [22]. In addition,
activation of p53 requires distinct inducers in response to different types of stimuli. To address the issue,
several p53 upstream genes were later added to the basic p53-Mdm2 negative feedback loop [25]. Based
on this, several advanced models of p53 feedback loops were established. Among them, the negative
feedback loops of ataxia telangiectasia mutated (ATM)-p53-wip-Mdm2 loop and ataxia-telangiectasia
and Rad3 kinase (ATR)-p53-Mdm2 are two popular ones (Figure 3) [8]. Besides the p53-Mdm2
feedback loop, two additional p53-ubiquitin ligases, Cop1 and Pirh-1 have been also identified to
form a p53 negative feedback loop [25]. Later, more ubiquitin ligases are identified to be involved
in the regulation of p53 degradation. These include Pirh2, Trim24, and Arf-BP1 among others [26].
Moreover, several other ubiquitin ligases including Topors, Chip, Carp1, Carp2, p300, and CBP are
identified to specifically mediate poly-ubiquitination of p53 [27]. It should be also pointed out that
among the ubiquitin ligases, Mdm2 plays a central role among all the p53 feedback loops, whereas the
other ubiquitin ligases mainly substitute the roles of Mdm2 to complement the deficiency of Mdm2 in
Mdm2-deficient cells [25,26].
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p53 can be activated by a variety of stimuli including IR, UV radiation, activated oncogenes,
p53 can be activated by a variety of stimuli including IR, UV radiation, activated oncogenes,
hypoxia, and chemotherapeutic drugs. However, our current understanding about the p53‐
hypoxia, and chemotherapeutic drugs. However, our current understanding about the p53-mediated
mediated stress response mainly results from the response to double‐strand DNA breaks (DSBs)
stress response mainly results from the response to double-strand DNA breaks (DSBs) induced by
induced by IR and single‐strand DNA breaks (SSBs) induced by UV radiation [23,24,28]. The
IR and single-strand DNA breaks (SSBs) induced by UV radiation [23,24,28]. The response of p53
response of p53 to SSBs is mediated by a less‐sensitive stress sensor, ATR [28], which activates p53
to SSBs is mediated by a less-sensitive stress sensor, ATR [28], which activates p53 and promotes
and promotes degradation of Mdm2, thereby leading to an increased level and activity of p53.
degradation of Mdm2, thereby leading to an increased level and activity of p53. Although activated
Although activated p53 can also upregulate Mdm2 expression, Mdm2 protein degradation is much
p53 can also upregulate Mdm2 expression, Mdm2 protein degradation is much faster than its protein
faster than its protein synthesis. This results in a low level of Mdm2 protein that in turn leads to a
synthesis. This results in a low level of Mdm2 protein that in turn leads to a sustainable level of p53.
sustainable level of p53. This further leads to a prolonged p53 pulse that subsequently activates pro‐
This further leads to a prolonged p53 pulse that subsequently activates pro-apoptotic downstream
apoptotic downstream effectors [28]. Although this model is supported by some experimental
effectors [28]. Although this model is supported by some experimental results, it needs to be confirmed
results, it needs to be confirmed by additional evidence that can illustrate the roles of the ATR‐p53‐
by additional evidence that can illustrate the roles of the ATR-p53-Mdm2 negative feedback loop
Mdm2 negative feedback loop in mediating the response of p53 to UV radiation. The response of
in mediating the response of p53 to UV radiation. The response of p53 to DSBs is mediated by the
p53 to DSBs is mediated by the ATM‐p53‐Wip loop [29]. In this loop, IR‐induced DSBs are initially
ATM-p53-Wip loop [29]. In this loop, IR-induced DSBs are initially detected by ATM, which then
detected by ATM, which then activates itself by auto‐phosphorylation. Subsequently, Mdm2 is
activates itself by auto-phosphorylation. Subsequently, Mdm2 is degraded, and p53 protein is stabilized
degraded, and p53 protein is stabilized and activated via phosphorylation. Activated p53 then
and activated via phosphorylation. Activated p53 then transactivates Wip1, a phosphatase that
transactivates Wip1, a phosphatase that dephosphorylates activated ATM. This creates a negative
dephosphorylates activated ATM. This creates a negative feedback loop between ATM and p53 [29,30].
feedback loop between ATM and p53 [29,30]. Thus, ATM‐dependent phosphorylation prevents
Thus, ATM-dependent phosphorylation prevents Mdm2 from binding and ubiquitinating p53, leading
Mdm2 from binding and ubiquitinating p53, leading to stabilization of p53 and further
to stabilization of p53 and further transactivation of Mdm2 gene. The feedback loop appears to be
transactivation of Mdm2 gene. The feedback loop appears to be involved in the initiation of
involved in the initiation of transient p53 pulses in response to IR because silencing of the WIP1 gene
transient p53 pulses in response to IR because silencing of the WIP1 gene can result in the dynamics
can result in the dynamics induced by UV-like stimuli [31]. It has been shown that ATM responds to
induced by UV‐like stimuli [31]. It has been shown that ATM responds to DNA strand breaks fairly
DNA strand breaks fairly efficiently. One or two DSBs in the human genome are sufficient to partially
efficiently. One or two DSBs in the human genome are sufficient to partially activate ATM, and less
activate ATM, and less than 20 DSBs can lead to full ATM activation [32]. Thus, transient p53 pulses
than 20 DSBs can lead to full ATM activation [32]. Thus, transient p53 pulses mediated by ATM are
mediated by ATM are highly sensitive to IR stimuli.
highly sensitive to IR stimuli.
Because IR-induced p53 pulses are fixed in amplitude and duration, it was initially proposed
Because IR‐induced p53 pulses are fixed in amplitude and duration, it was initially proposed
that the decision of cell fate is governed by the frequency of p53 pulses [31]. It is conceivable that
that the decision of cell fate is governed by the frequency of p53 pulses [31]. It is conceivable that a
a low dose of IR induces transient p53 pulses with a low frequency, which in turn leads to cell cycle
low dose of IR induces transient p53 pulses with a low frequency, which in turn leads to cell cycle
arrest and subsequently to cell survival and recovery. In contrast, a high dose of IR induces a high
arrest and subsequently to cell survival and recovery. In contrast, a high dose of IR induces a high
frequency of p53 pulses, and if the frequency exceeds a threshold, apoptosis occurs. The transient
frequency of p53 pulses, and if the frequency exceeds a threshold, apoptosis occurs. The transient
p53 pulse mode can prevent the p53 protein level from being over‐activated, allowing cells to
recover from DNA damage. Thus, this mode only results in pro‐arrest cellular responses [31,33].
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have shown that in response to UV radiation, p53 exhibits a single prolonged pulse that is associated
with the irreversible cell fate—apoptosis [28]. In contrast, in response to IR, p53 employs a two-phase
response to determine cell fate [13]. In the first phase, the protein level of p53 acts as a series of transient
pulses leading to cell cycle arrest and recovery. If IR-induced DNA damage is repaired, p53 dynamics
will return to a normal status, and cells will survive. However, if DNA damage remains, p53 dynamics
will enter into the second phase during which the dynamics of p53 are switched from a transient pulse
mode to a sustained mode with a high level of p53 protein that triggers apoptosis. Thus, the two-phase
cell fate decision mechanism mediated by p53 dynamics ensures a flexible and efficient regulation that
can avoid a premature apoptosis process as well as initiate the execution of apoptosis.
It is noteworthy that the majority of studies on p53 dynamics focus on how p53 responds to stimuli,
i.e., exogenous DNA damaging agents such as IR and UV radiation. Few studies explore how p53 reacts
to intrinsic or spontaneous DNA damage caused by normal physiological processes. With quantitative
time-lapse microscopy of individual human cells (MCF7 cell line), a recent study showed that p53
exhibits excitable spontaneous transient pulses in non-stressed cells to respond to spontaneous DNA
damage with a dynamic pattern similar to that in response to IR [32]. This finding indicates that p53
can also be quickly activated in response to spontaneous DNA damage in cells. This further indicates
that the dynamics of p53 protein level as a part of “p53 dynamics” govern cell signaling that mediates
cellular responses to both endogenous/spontaneous and exogenous/environmental DNA damage.
3. The Dynamics of p53 That Are Independent of Its Cellular Protein Level
In general, p53 dynamics are designated as the variation in p53 protein level in response to
stimuli. However, this notion has been challenged by the fact that the maintenance of a steady level
of p53 protein induced by IR with a p53-stabilizing agent only can switch cell fate from survival to
irreversible senescence [19]. This is different from the UV-induced outcome, apoptosis. This suggests
that the dynamics of p53 protein level probably represent only one aspect of p53-mediated cell fate
decision. It appears that other aspects of the dynamics of p53, such as their spatial location and
post-translational modifications, may also play crucial roles in mediating cellular DNA damage
responses by coordinating with the dynamics of its protein level.
3.1. The Spatial Dynamics of p53 in Cells
As a transcription factor, p53 is continuously transported among the nucleus, cytosol,
and mitochondria. Export of p53 from the nucleus to mitochondria is thought to be a negative
regulation of p53 transcription activity by excluding the protein from its target genes. Yet, recent studies
have shown that non-transcriptional mitochondrial p53 proteins also play an important role in p53
dynamics at the spatial level of the protein [36–38].
Because of its regulatory roles in gene transcription, p53 proteins are mainly located in the nucleus,
where they bind to the promoter and/or enhancer of the target genes to regulate gene expression. Yet,
a small portion of p53 protein is located in mitochondria to perform its non-transcriptional function.
It appears that such a small amount of p53 in mitochondria is sufficient to mediate mitochondrial
apoptosis effectively [36,39]. Upon DNA damage, p53 translocates into the mitochondrial outer
membrane to interact with Bcl2 family members, Bak/Bax. This promotes Bak/Bax oligomerization,
leading to mitochondrial outer membrane permeabilization, cytochrome c release, caspase-3 activation,
and apoptosis [37,40,41]. Thus, mitochondrial p53 exhibits a pro-apoptotic activity and acts much
faster than nuclear p53. It has been reported that p53 can accumulate in mitochondria within 30 min of
stimuli exposure to trigger apoptosis prior to the activation of p53 target pro-apoptotic genes in the
nucleus [38].
It appears that nuclear and mitochondrial p53 are orchestrated to determine the fate of cells that
are damaged by IR [9]. This has been described in a computational model, where depending on the
severity of DNA damage, three types of cellular outcomes would occur: survival, cell cycle arrest,
and subsequent and immediate apoptosis without repair. If the damage is severe and can result in
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full phosphorylation of p53 at Ser-15/20/46, mitochondrial p53 can directly activate apoptosis to
eliminate severely damaged cells. If the damage is less severe and can only partially phosphorylate
p53 at Ser-15/20, p53 can then accumulate in the nucleus and act as a transcription factor to mediate
the “two-phase cell fate decision mechanism” described in Section 2.2. Thus, p53 can save cells that
are less severely damaged, but direct cells that are severely damaged to apoptosis.
3.2. The Dynamics of Posttranslational Modifications of p53
The posttranslational modifications of p53—including ubiquitinylation, phosphorylation,
methylation, and acetylation [42]—play important biological functions. Ubiquitinylation of p53
is mainly mediated by Mdm2 [21]. The post-translational modification of p53 was initially identified
in the 1990s as a key regulator of the protein by promoting proteasomal degradation of p53 [22]. Later,
multiple types of Mdm2-mediated p53 ubiquitinylation were identified [21,43]. It has been found that
polyubiquitinylated p53 with a polymeric ubiquitin chain containing at least four ubiquitin subunits
attached to a single lysine residue of the protein, is destined to proteasomal degradation. In contrast,
monoubiquitinylated p53, conjugated only with a single ubiquitin moiety attached to one or multiple
lysine residues, is stabilized. Moreover, monoubiquitinylated p53 is involved in sub-cellular trafficking
including nuclear export and mitochondrial translocation, which facilitate mitochondrial p53-activated
apoptosis [43]. These findings suggest that Mdm2-mediated p53 ubiquitinylation is dynamic in nature.
In fact, it also has been suggested that a switch between the two types of p53 ubiquitinylation plays
an essential role in coordinating two types of p53 dynamics—the varying p53 protein levels and
spatial locations—thereby creating a path of spatiotemporal cell fate decision. It should be noted that
recent studies have identified a deubiquitination process that can reverse the effects of ubiquitination
of p53 and its degradation. This is accomplished by several deubiquitination enzymes including
USP7 that deubiquitinates Mdm2 to stabilize p53 [44] as well as USP10 and USP42 that can directly
deubiquitinate p53 upon DNA damage [45,46]. Thus, ubiquitination and deubiquitination of p53 may
provide an alternative mechanism for regulating and fine-tuning p53 dynamics and cell fate decision.
Discovery of the dynamics of p53 ubiquitinylation also led to the discovery of the dynamics of
other types of post-translational modifications of p53 (Figure 5). Thus far, there are at least 30 amino
acid residues in the p53 protein that have been identified as posttranslational modification sites.
Many of the sites can be modified by multiple types of posttranslational modifications that include
phosphorylation, acetylation, methylation, and SUMOylation among others (Figure 5). In addition,
one type of posttranslational modification can occur on multiple sites of the p53 protein. This unique
feature provides a basis for the dynamic changes of various types of p53 modifications at one specific
site as well as the dynamics of one specific type of p53 modification at multiple sites. During the process
of phosphorylation of p53 for its activation [47], p53 is primarily phosphorylated at Ser-15/20, and then
phosphorylated at Ser-46 if stress is sustained [48,49]. The Wang group has developed a computational
model to illustrate the biological function of this sequential process of phosphorylation of p53. In this
model, it is proposed that the dynamics of p53 phosphorylation can regulate the transcription activity
of p53, governing transactivation of p53 target genes selectively [13]. In this scenario, p53 initially
exhibits transient pulses in response to IR. This primarily results in phosphorylation of p53 at Ser-12/20,
which then partially activates p53 and induces pro-arrest genes for damage repair. If the damage is
detected as “the one that cannot be repaired”, p53 is further phosphorylated at Ser-46, and this in turn
activates p53 transactivated pro-apoptotic genes leading to the removal of cells containing unrepaired
DNA damage via apoptosis.
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3.3. Roles of MicroRNAs (miRNAs) in Modulating p53 Dynamics
Recent studies have shown that besides its crucial role in regulating gene expression, p53 can also
activate its target miRNAs, which include miR-192, miR-194, miR-215, miR-107, and miR-605 [51,52].
Interestingly, among the miRNAs, miR-605, miR-143, and miR-145 induced by p53 can also enhance
p53 activation by suppressing the translation of Mdm2 mRNA and its protein synthesis [53]. On the
other hand, p53-induced miR-16 and miR-34a can promote p53-induced apoptosis by suppressing
the expression of an anti-apoptotic protein, Bcl-2 [54], an anti-apoptotic protein that can inhibit
p53-regulated apoptosis-inducing protein 1 (p53AIP1) by forming a Bcl2-p53AIP protein complex [55].
The roles of miRNAs in modulating p53 dynamics have been illustrated in a computational model that
describes the roles of miR-605 and miR-34a in IR-induced p53 dynamics [56]. In this model, IR-induced
DSBs activate DNA damage sensor ATM that in turn activates p53. Activated p53 subsequently
upregulates the expression of Mdm2 and miR-605, which in turn suppresses the translation of
Mdm2 mRNA, thereby promoting the activity of p53 [57]. Thus, p53, miR-605, and Mdm2 constitute
a positive feedback loop that facilitates a series of transient pulses resulting in cell cycle arrest and
recovery. On the other hand, miR-34a contributes an additional effect to this positive feedback
loop by suppressing the expression of Bcl-2 upon severe DNA damage that cannot be repaired by
cells. This then allows release of cytochrome C and initiation of caspase-3 cascade for apoptosis [58].
This model demonstrates that p53-targeted miRNAs play crucial roles in modulating p53 dynamics
and signaling network.
3.4. The Network of p53 Dynamics in Governing Cell Fate and Cancer Therapy
Our current understanding of p53 dynamics is limited to the pulsatile switches of its protein level.
However, the interplay among different types of p53 dynamics is critical in governing a specific cellular
damage response. Based on this, p53 dynamics can be designated as a multi-faceted dynamic network
comprised of all variables that can be measured over time. These include p53 protein level, its activity,
subcellular localization and posttranslational modifications. We therefore propose a model that
illustrates the roles of multiple dynamic features of p53 in governing cell fate (Figure 6). In non-stressed
cells, p53 exhibits spontaneous transient pulses that are usually triggered by endogenous DNA damage.
In this scenario, because damage signals are not sustainable, the posttranslational modifications of
p53, including deacetylation and methylation at residues K373 and K382, result in inactivation of p53
protein, thereby preventing it from inducing cell cycle arrest. In cells that are attacked by stressors,
such as UV radiation, oncogene activation, and IR, continuous production of DNA damage, including
SSBs or DSBs, can activate p53 transcription activity. In response to UV radiation and activated
oncogenes, p53 exhibits a single prolonged pulse that subsequently leads to an irreversible apoptotic
process. In response to IR-induced DNA damage, p53 regulates cell fate by causing three different
types of consequences—i.e., survival, apoptosis after damage repair, and immediate apoptosis. Thus,
when IR-induced damage occurs, it is repeatedly evaluated by cells for determining their fates.
If the damage is too severe to be repaired, p53 will translocate from the nucleus to mitochondria.
This will rapidly trigger a transcription-independent apoptotic process eliminating severely damaged
cells without consuming energy. If the damage is repairable, p53 will stay in the nucleus and act
as a transcription factor. In this scenario, p53 will exert a series of transient pulses promoting its
primary modifications such as acetylation and demethylation at K373 and K382, and subsequent
phosphorylation at Ser-15/20. This will partially activate p53, resulting in upregulation of pro-arrest
gene expression that in turn facilitates damage repair. Cells will then determine whether the damage is
sufficiently repaired or not. If the damage is fully repaired, p53 will return to an inactive status, and cells
will survive. Otherwise, p53 pulses will switch from a transient to a sustained mode. This will then
initiate additional posttranslational modifications of p53, mainly phosphorylation at Ser-46. This will
completely activate p53 and ultimately activate pro-apoptotic gene expression and apoptosis.
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cancer therapy, which solely focuses on inhibition of Mdm2, may have its limitations. A dual role of
Mdm2 in serving as both an oncoprotein and a tumor suppressor should be considered in an effort
to improve anticancer therapeutic efficacy. Based on this, a Mdm2-based cancer therapy can be
achieved by two approaches: (1) Since Mdm2 mediated mono-ubiquitinylation of p53 is the key for
p53 spatial trafficking and subsequent apoptosis initiation, inhibition of polyubiquitinylation of p53
can lead to an effective therapy. Some compounds that can deubiquitinylate p53 such as USP10 may
be used as a potential therapy [61]; (2) Based on the fact that the competition between nuclear p53 and
mitochondrial p53 governs the non-transcription dependent apoptosis, inhibitors of nuclear p53 can
be used to enhance the mitochondrial p53-triggered rapid apoptosis process, thereby increasing the
efficacy of chemotherapeutics.
In a scenario where the mitochondrial p53-mediated apoptotic pathway fails to be initiated,
a nuclear p53-mediated apoptosis can be initiated as an alternative pathway to promote cell death.
A critical step of this process is to promote p53 transactivation of pro-apoptosis genes. Based on
the fact that p53 transcriptional activity is determined by both its protein level and posttranslational
modifications, two strategies can be employed to alter p53 transcriptional activity. One is to switch
p53 pulses from a transient mode to a sustained mode. Defects in this switch have been identified
in human cancers in a tissue-specific manner. For example, Wip1, a phosphatase, is essential for
the initiation of transient p53 pulses. Thus, it acts as an oncogene in many cancers such as breast
cancer, glioma, and colon carcinoma [62]. In contrast, PTEN, a tumor suppressor that can induce
a sustained p53 pulse, is not expressed in MCF-7 human breast cancer cells [13]. Thus, inhibition of
Wip1 or stimulation of PTEN can alter the p53 dynamic pattern, thereby facilitating p53-dependent
apoptosis and improving cancer treatment efficacy in a tissue-specific manner. The other strategy is to
switch p53 phosphorylation from partial to full. This can be achieved by altering a hub within the p53
phosphorylation process, stimulating p53 phosphorylases such as DYRK or inhibiting phosphatases
such as Wip1. It should also be noted that the cellular level of p53 appears to be the key that underlies
p53 transcriptional activity, yet it is delicately regulated by the posttranslational modifications of the
protein resulting in a specific pattern of p53 dynamics in cells. This provides a variety of targets that
can be modulated for regulating cellular level of p53 and manipulating cell fate. However, the multiple
dynamic features of p53 are also challenges to the current p53-based cancer therapeutic strategies.
In addition, the effects of p53 mutants on p53 dynamics can modulate the efficacy of p53-based cancer
therapy. It has been found that in tumor cells, most p53 mutant proteins bear a surface cleft that
mediates its physical interaction with Mdm2, thereby leading to p53 degradation [63,64]. It appears
that for the treatment of such a type of tumors, a therapy that increases the p53 level by extending the
half-life of p53 should be a priority before a p53 dynamics-based therapy can be considered. This can
be achieved by p53 gene-transfer or p53 activator drugs, such as Prima-1(Met)/Apr-246 and phenethyl
isothiocyanate (PEITC) so that the cellular level and activity of p53 may be restored to normal [64,65].
Thus, different strategies may be adopted for p53-based cancer therapy upon the different types of p53
deficiency in tumor cells.
4. Conclusions
The dynamics of p53 have emerged recently as a new field of cell signaling. However, its biological
significance remains to be elucidated. With the development of fluorescent labeling and time-lapse
technology, studies on p53 dynamical profiles in protein level, spatial location, and posttranslational
modifications will provide new insights into the biological function and implications of p53 dynamics in
cancer treatment. Because p53 dynamics have been mainly studied in IR-induced DNA damage models,
many of which are based on computational and mathematic approaches, additional experimental
results that support these models are in urgent need. These include the results of p53 dynamics induced
by other stimuli such as ROS, heavy metals, and chemotherapeutic drugs. In addition, because the
measurements of p53 dynamics are currently restricted in cultured cells, the dynamic profiles of this
protein need to be further verified in a biological system such as fruit flies, worms, zebra fish, mice,

Genes 2017, 8, 66

13 of 16

and humans, if it is feasible. Nevertheless, our knowledge about dynamic interactions among various
cell signaling networks and the dynamics of the components of the network will provide valuable
guidance to manipulate and control cell signaling pathways for achieving therapeutic purposes in
both cancer and other human diseases such as neurodegenerative diseases.
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